CURIS, INC. Short-Term Debt
CURIS, INC. (CRIS) had Short-Term Debt of $6.92 million as of 2018-12-31, per its 10-K filed 2020-03-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DebtCurrent · last filed 2020-03-19
- 2018-12-31: Debt, Current $6.92M.
- 2017-12-31: Debt, Current $5.92M.
| Period end | Debt, Current |
|---|---|
| 2018-12-31 | $6.92M 10-K · filed 2020-03-19 |
| 2017-12-31 | $5.92M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |